Genelux introduces appealing information from 2 stage I tests of GL-ONC1 in head as well as neck cancer cells as well as mesothelioma cancer – Medical News
Health & Medical News Journal

Genelux introduces appealing information from 2 stage I tests of GL-ONC1 in head as well as neck cancer cells as well as mesothelioma cancer

Genelux Introduces Appealing Information From 2 Stage I Tests Of GL-ONC1 In Head As Well As Neck Cancer Cells As Well As Mesothelioma Cancer

. .

.
. GL-ONC1, the firm’s lead oncology item prospect, is an undermined vaccinia infection (Lister stress). GL-ONC1 is presently under analysis in several Phase 1 and also 1/2 scientific tests in the U.S. and also Europe.

. . . .

.

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.